The introduction of lanreotide, in the form of Somatuline Autogel ® (SCRAS, Paris, France)—which does not require reconstitution before injection and is available in ready-to-use, prefilled ...
Lanreotide 60mg/0.2mL, 90mg/0.3mL, 120mg/0.5mL; prolonged-release soln for SC inj. Lanreotide, the active component of Somatuline Depot is an octapeptide analog of natural somatostatin. The ...
Median PFS improved from 11.5 months with single-agent everolimus to 29.7 months with the addition of lanreotide. Objective responses occurred about three times as often with the combination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback